[Abstract] Gerontology
Their findings revealed that BBR ameliorated the community of intestinal microbiota and significantly promoted the abundance of beneficial bacteria such as Muribaculaceae and Akkermansia
[DOI] [PMC free article] [PubMed] [Google Scholar] 146.Hutchison A.T., Piscitelli D., Horowitz M., Jones K.L., Clifton P.M., Standfield S., Hausken T., Feinle-Bisset C., Luscombe-Marsh N.D
The TRANSCEND-T2D-1 trial reported in March 2026 found 16.8% weight loss and a 2.0% reduction in HbA1c (a marker of average blood sugar) at the 12 mg dose over 40 weeks in adults living with type 2 diabetes
The devolved nations assess medications separately
The regions large and diverse population presents a significant opportunity for market expansion, especially as awareness of innovative weight loss therapies continues to rise